Ekso Bionics CEO Peurach resigns; Chairman Sherman becomes CEO

EKSO BIONICS HOLDINGS, INC.

CEO Jack Peurach resigns effective Jan 21, 2022; receives severance of 9 months salary, $187,250 lump sum, and RSU acceleration.
Chairman Steven Sherman appointed CEO effective Jan 22; will receive equity award in lieu of $453K annual cash salary.
Scott Davis promoted to President and COO from EVP Strategy and Corporate Development.
Board appoints new committee chairs; Stanley Stern becomes Lead Independent Director.
Press release notes record Q4 2021 revenue and momentum in inpatient rehab and industrial sales.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stanley Stern

Lead Independent Director

CHRN · EKSO BIONICS HOLDINGS, INC.

Filed: January 21, 2022, 6:59 PM ET

Board member Stanley Stern has been designated the Board’s lead independent director.

Appointed

Steven Sherman

Chief Executive Officer

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2022-01-22
Filed: January 21, 2022, 6:59 PM ET

the Company’s Board appointed Steven Sherman, who currently serves as the Chairman of the Board, to become Chief Executive Officer of the Company effective January 22, 2022.

Departed

Jack Peurach

President, Chief Executive Officer and a director

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2022-01-21
Successor: Steven Sherman
Filed: January 21, 2022, 6:59 PM ET

Jack Peurach, the President, Chief Executive Officer and a director of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his intention to resign as an officer and member of the Board of Directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Stanley Stern was appointed as Lead Independent Director at EKSO BIONICS HOLDINGS, INC..

Action: designated
Role: Lead Independent Director

Exact text from the filing

Board member Stanley Stern has been designated the Board’s lead independent director.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Sherman was appointed as Chief Executive Officer at EKSO BIONICS HOLDINGS, INC..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

the Company’s Board appointed Steven Sherman, who currently serves as the Chairman of the Board, to become Chief Executive Officer of the Company effective January 22, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jack Peurach resigned as President, Chief Executive Officer and a director at EKSO BIONICS HOLDINGS, INC..

Action: resigned
Role: President, Chief Executive Officer and a director

Exact text from the filing

Jack Peurach, the President, Chief Executive Officer and a director of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his intention to resign as an officer and member of the Board of Directors

View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-006468

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.